Home Press Release north-america-iga-nephropathy-market
Press Release

Aug, 16 2022

Teva Pharmaceuticals USA, Inc.、Viatris Inc. 和 Novartis AG 主導了 2020 年北美 IgA 腎臟病市場

預計北美伊賀腎病變市場在 2021 年至 2028 年的預測期內將以 19.7% 的複合年增長率成長。研究考慮的年份如下。

訪問完整報告 @ https://www.databridgemarketresearch.com/reports/north-america-iga-nephropathy-market

北美 IgA 腎病市場是一個高度擴張的市場，其中包括一定數量的關鍵參與者和本地參與者。市場見證了藥物研發和臨床試驗的不斷增加，以開髮用於治療的新型創新藥物。

北美 IgA 腎病市場的主要參與者正在推出一系列強大的產品組合。這有助於公司透過增強產品組合來實現銷售額最大化。

 例如，

  • 2020年9月，邁蘭公司和輝瑞公司的合併公司Viatris Inc.獲得歐盟批准。此外，該公司還獲得了澳洲競爭與消費者委員會和紐西蘭委員會的批准，增強了其公司成立提案的力度。這項批准使該公司能夠成立一家新公司，以滿足患者的需求

Teva Pharmaceuticals USA, Inc.（Teva Pharmaceutical Industries Ltd. 的子公司）是北美 IgA 腎臟病市場的主導者。市場上現有的其他主要參與者包括 Viatris Inc.、阿斯特捷利康、諾華股份公司、輝瑞公司、Zydus Cadila、Fresenius Kabi USA（Fresenius SE & Co. KGaA 的子公司）、Hikma Pharmaceuticals PLC、LUPIN、Accord Healthcare Ltd. Dohme Corp.（默克公司的子公司）、CareDX, Inc.、Alembic Pharmaceuticals Limited、Strides Pharma Science Limited、Apotex Inc.、Caliditas Therapeutics AB、Omeros Corporation 等。

北美IgA腎病市場Teva Pharmaceuticals USA, Inc.

Teva Pharmaceutical USA Inc. 總部位於美國新澤西州，公司專注於改善健康和生活的創新治療和優質仿製藥。該公司經營多種產品組合，如產品目錄、仿製藥、專科藥物、生物製藥、報告不良反應、患者資源、貿易夥伴信息，而仿製藥是市場重點類別。

  • 2021 年 10 月，Teva Pharmaceuticals USA, Inc. 宣布推出 FDA 批准的用於治療 HIV-1 和腎衰竭的 TRUVADAi 和 ATRIPLA I 片劑的仿製藥。在 COVID-19 大流行期間，對於免疫功能低下且有更嚴重疾病風險的人來說，獲得治療比以往任何時候都更加重要。這種新產品將推動醫院和診斷中心仿製藥的淨銷售額和分銷量上升。預計市場將實現線性成長

該公司的業務遍及美洲、歐洲、中東和非洲以及亞太地區。

維亞特里斯公司

Viatris Inc 總部位於美國賓州，成立於 1961 年。該公司致力於為全球患者提供更多可負擔的優質藥品，無論其地理或情況如何。該公司提供各種類別的廣泛產品，例如 Legacy Mylan 產品、Legacy Upjohn 產品，其中 Legacy Mylan 產品、Legacy Upjohn 產品是市場重點類別。

例如，

  • 2020年10月，邁蘭公司和輝瑞公司合併後的公司Viatris Inc.獲得美國聯邦貿易委員會的批准。此次批准為成立新公司鋪平了道路，強調開發創新藥物和突破以改變患者的生活。此項批准開啟了公司未來的發展

該公司的業務範圍廣泛，遍及亞太地區、美洲和歐洲。該公司在 Rottapharm 設有子公司 | Madaus GmbH（德國）、MEDA Pharma GmbH, and Co. KG（德國）、Merck Generics Belgium BVBA（比利時）、Arcana Arzneimittel GmbH（德國）、Mylan Laboratories India Private Ltd（印度）等。

諾華公司

諾華公司總部位於瑞士巴塞爾，成立於1996年。公司致力於投資最有前景的科學前沿、醫藥行業最令人興奮的創新以及最重要的醫療保健需求。該公司的各種產品包括癌症、心血管、腎臟和代謝、免疫學和皮膚病學、眼科、神經科學和呼吸系統。其中，腎臟和代謝是市場重點關注的類別。

例如，

  • 2020 年 12 月，諾華公司宣布，美國 FDA 已批准 iptacopan (LNP023) 的突破性療法認定，用於治療陣發性睡眠性血紅蛋白尿 (PNH) 和罕見兒科疾病 (RPD)，以及治療 C3 腎小球病 (C3G)。突破性認定將處理治療腎臟疾病慢性醫療需求的藥物的開發和審查。這將使患者得到及時治療，並在預測期內增加對新療法的需求

該公司的業務遍及亞太地區、歐洲、美洲、中東和非洲。公司旗下擁有諾華澳大利亞有限公司（澳洲）、諾華奧地利有限公司（奧地利）、諾華製藥有限公司（比利時）、諾華證券投資有限公司（漢密爾頓）、諾華生物科學有限公司（巴西）、山德士（中國）製藥有限公司（中國）等子公司。

CHOOSE LICENCE TYPE

  • 7000
  • 4800
  • 3000
  • 8000
  • 12000
Buy Now
Advance Formative Research Customization Request for bulk Reports
Banner

Latest Press Release

Rising Growth of Smart Homes and Smart City Initiatives is Driving the Global Smart Security Market
Key Industry Verticals Fueling Sustained Market Growth
Growth in Domestic Vehicle Manufacturing and Assembly Activities Fuels Market Growth
Surge in Demand for Luxury Cosmetic and Fragrance Packaging is the Driving Factor in the Market
Rising Demand for Advanced Driver Training and Safety Education Is Driving the Global Driving Simulator Market
Rapid Expansion of AI and Machine Learning Adoption Across Industries, Increasing the Need for Large Volumes of Accurately Labeled Training Data is the Driving Factor in the Market
VIEW ALL

Browse Related Press Release

YOU MAY ALSO BE INTERESTED IN

Client Testimonials

Claudio Rondena
Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Client Logo
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Client Logo
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Client Logo
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I'm glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Client Logo
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Client Logo
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Client Logo
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Client Logo
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Client Logo
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Client Logo
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It's been very helpful in our business planning and it well organized.

Client Logo
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Client Logo
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist, Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future